Boston Scientific today shared new findings supporting intravascular ultrasound (IVUS)-guided percutaneous coronary ...
Evident Vascular, a company creating AI-enabled intravascular ultrasound technology, announced its launch today with $35 million in Series A financing. Vensana Capital led the round. The ...
The controversial findings had interventional cardiologists looking for answers, with operator experience coming into focus.
ATLANTA -- The use of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with acute coronary syndromes resulted in better outcomes compared with ...
The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...
Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than ...
WASHINGTON, DC – A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional ...
Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch SAN JOSE, Calif.–(BUSINESS WIRE)–March 25, 2025– Evident ...
Late breaking trial data examining intravascular ultrasound (IVUS) and treatment benefits in cardiac allograft vasculopathy (thickening of arterial walls) were presented yesterday at the 24th Annual ...
Serial studies using IVUS enable assessment of the progression or regression of coronary atherosclerosis by visualizing the occurrence of atheroma in the vessel wall. A previous study using IVUS ...
Arterial and deep venous disease are on the rise: more than 21 million people in the U.S. had peripheral arterial disease (PAD) in 2020, a number that’s expected to rise to 24 million by 2030, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results